EcoDrugPlus


Trade Names	MULTIHANCE MULTIHANCE MULTIPACK
Synonyms	B-19036 B1903617 Gadobenate Gadobenate dimeglumine Gadobenic acid Gadobenic acid meglumine Gadobenoate dimeglumine Meglumine gadobenate Multihance Multihance multipack
Status
Molecule Category	UNKNOWN
UNII	3Q6PPC19PO

Trade Names

MULTIHANCE

MULTIHANCE MULTIPACK

Synonyms

B-19036

B1903617

Gadobenate

Gadobenate dimeglumine

Gadobenic acid

Gadobenic acid meglumine

Gadobenoate dimeglumine

Meglumine gadobenate

Multihance

Multihance multipack

Status

Molecule Category

UNKNOWN

UNII

3Q6PPC19PO


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C29H45GdN4O16
Molecular Weight	862.94
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C29H45GdN4O16

Molecular Weight

862.94

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Mechanism of Action	Action	Reference
Diagnostic agent	None	DailyMed

Mechanism of Action

Action

Reference

Diagnostic agent

None

DailyMed

Resources	Reference
ChEMBL	CHEMBL1200571
FDA SRS	3Q6PPC19PO
PubChem	197281

Resources

Reference

ChEMBL

CHEMBL1200571

FDA SRS

3Q6PPC19PO

PubChem

197281


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

GADOBENATE DIMEGLUMINE

Physicochemical Descriptors

Bioactivity

Cross References